Eli Lilly obesity pill disappoints in trial, sending shares down 12%

All NewsAugust 7, 2025

Rival Novo Nordisk’s stock climbs 12%

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent